J Clin Microbiol. 1992 November; 30(11): 2917-2920
Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures.
J M Pepin,
F Simon,
A Dussault,
G Collin,
M C Dazza and
F Brun-Vezinet
Department of Virology, Claude Bernard Hospital, Paris, France.
ABSTRACT
We were able to rapidly determine the susceptibility of human cytomegalovirus to ganciclovir using a late antigen synthesis reduction assay directly on primocultures of clinical specimens. This test was compared with a conventional susceptibility assay which was performed with cell-free virus obtained after cytomegalovirus isolation and in vitro passages. Both tests produced similar results. The rapid test, unlike conventional assays, is able to provide a result within 5 days after receipt of the specimen and could thus play a direct role in the therapeutic decision.
J Clin Microbiol. 1992 November; 30(11): 2917-2920
This article has been cited by other articles:
-
Baldanti, F., Gerna, G.
(2003). Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. J Antimicrob Chemother
52: 324-330
[Abstract]
[Full Text]
-
Erice, A.
(1999). Resistance of Human Cytomegalovirus to Antiviral Drugs. Clin. Microbiol. Rev.
12: 286-297
[Abstract]
[Full Text]
-
McSharry, J. J., Lurain, N. S., Drusano, G. L., Landay, A. L., Notka, M., O'Gorman, M. R. G., Weinberg, A., Shapiro, H. M., Reichelderfer, P. S., Crumpacker, C. S.
(1998). Rapid Ganciclovir Susceptibility Assay Using Flow Cytometry for Human Cytomegalovirus Clinical Isolates. Antimicrob. Agents Chemother.
42: 2326-2331
[Abstract]
[Full Text]
Copyright © 1992 by the American Society for Microbiology. All rights reserved.